nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—TGM7—testis—muscle cancer	0.0219	0.032	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—PTMA—muscle cancer	0.0165	0.158	CbGpPWpGaD
L-Glutamine—TGM4—testis—muscle cancer	0.0126	0.0184	CbGeAlD
L-Glutamine—GLS—embryo—muscle cancer	0.0107	0.0156	CbGeAlD
L-Glutamine—TGM2—embryo—muscle cancer	0.0106	0.0155	CbGeAlD
L-Glutamine—NADSYN1—Nicotinate metabolism—PTGS2—muscle cancer	0.00993	0.0951	CbGpPWpGaD
L-Glutamine—TGM5—vagina—muscle cancer	0.00979	0.0143	CbGeAlD
L-Glutamine—TGM1—cardiac atrium—muscle cancer	0.00979	0.0143	CbGeAlD
L-Glutamine—GFPT2—embryo—muscle cancer	0.00978	0.0143	CbGeAlD
L-Glutamine—CCBL1—renal system—muscle cancer	0.0086	0.0126	CbGeAlD
L-Glutamine—GATB—renal system—muscle cancer	0.0086	0.0126	CbGeAlD
L-Glutamine—QARS—embryo—muscle cancer	0.00834	0.0122	CbGeAlD
L-Glutamine—TGM2—smooth muscle tissue—muscle cancer	0.00832	0.0121	CbGeAlD
L-Glutamine—GLS—renal system—muscle cancer	0.0081	0.0118	CbGeAlD
L-Glutamine—TGM2—renal system—muscle cancer	0.00801	0.0117	CbGeAlD
L-Glutamine—TGM1—vagina—muscle cancer	0.00792	0.0116	CbGeAlD
L-Glutamine—GATB—cardiac atrium—muscle cancer	0.0077	0.0112	CbGeAlD
L-Glutamine—CAD—embryo—muscle cancer	0.0077	0.0112	CbGeAlD
L-Glutamine—GFPT2—smooth muscle tissue—muscle cancer	0.00769	0.0112	CbGeAlD
L-Glutamine—CTPS1—renal system—muscle cancer	0.00754	0.011	CbGeAlD
L-Glutamine—GMPS—renal system—muscle cancer	0.00754	0.011	CbGeAlD
L-Glutamine—TGM3—vagina—muscle cancer	0.00742	0.0108	CbGeAlD
L-Glutamine—GFPT2—renal system—muscle cancer	0.00741	0.0108	CbGeAlD
L-Glutamine—TGM1—head—muscle cancer	0.00731	0.0107	CbGeAlD
L-Glutamine—TGM1—testis—muscle cancer	0.00707	0.0103	CbGeAlD
L-Glutamine—SLC38A3—testis—muscle cancer	0.00691	0.0101	CbGeAlD
L-Glutamine—TGM3—head—muscle cancer	0.00685	0.01	CbGeAlD
L-Glutamine—GLS2—vagina—muscle cancer	0.00679	0.00991	CbGeAlD
L-Glutamine—NADSYN1—vagina—muscle cancer	0.00679	0.00991	CbGeAlD
L-Glutamine—GATB—tendon—muscle cancer	0.00671	0.0098	CbGeAlD
L-Glutamine—CCBL1—tendon—muscle cancer	0.00671	0.0098	CbGeAlD
L-Glutamine—F13A1—renal system—muscle cancer	0.00665	0.0097	CbGeAlD
L-Glutamine—GFPT2—cardiac atrium—muscle cancer	0.00663	0.00968	CbGeAlD
L-Glutamine—PFAS—cardiac atrium—muscle cancer	0.00663	0.00968	CbGeAlD
L-Glutamine—TGM3—testis—muscle cancer	0.00662	0.00967	CbGeAlD
L-Glutamine—QARS—smooth muscle tissue—muscle cancer	0.00656	0.00958	CbGeAlD
L-Glutamine—GLS—tendon—muscle cancer	0.00632	0.00923	CbGeAlD
L-Glutamine—QARS—renal system—muscle cancer	0.00632	0.00922	CbGeAlD
L-Glutamine—NADSYN1—head—muscle cancer	0.00627	0.00915	CbGeAlD
L-Glutamine—GLS2—head—muscle cancer	0.00627	0.00915	CbGeAlD
L-Glutamine—CCBL1—vagina—muscle cancer	0.00623	0.00909	CbGeAlD
L-Glutamine—GATB—vagina—muscle cancer	0.00623	0.00909	CbGeAlD
L-Glutamine—GLS—bone marrow—muscle cancer	0.00612	0.00894	CbGeAlD
L-Glutamine—NADSYN1—testis—muscle cancer	0.00606	0.00884	CbGeAlD
L-Glutamine—GLS2—testis—muscle cancer	0.00606	0.00884	CbGeAlD
L-Glutamine—F13A1—cardiac atrium—muscle cancer	0.00595	0.00869	CbGeAlD
L-Glutamine—GMPS—tendon—muscle cancer	0.00589	0.0086	CbGeAlD
L-Glutamine—CTPS1—tendon—muscle cancer	0.00589	0.0086	CbGeAlD
L-Glutamine—GLS—vagina—muscle cancer	0.00586	0.00856	CbGeAlD
L-Glutamine—GFPT2—tendon—muscle cancer	0.00578	0.00844	CbGeAlD
L-Glutamine—PFAS—tendon—muscle cancer	0.00578	0.00844	CbGeAlD
L-Glutamine—CCBL1—head—muscle cancer	0.00575	0.0084	CbGeAlD
L-Glutamine—GATB—head—muscle cancer	0.00575	0.0084	CbGeAlD
L-Glutamine—GMPS—bone marrow—muscle cancer	0.0057	0.00833	CbGeAlD
L-Glutamine—CTPS1—bone marrow—muscle cancer	0.0057	0.00833	CbGeAlD
L-Glutamine—QARS—cardiac atrium—muscle cancer	0.00566	0.00826	CbGeAlD
L-Glutamine—PFAS—bone marrow—muscle cancer	0.0056	0.00818	CbGeAlD
L-Glutamine—Anorectal discomfort—Etoposide—muscle cancer	0.00556	0.0264	CcSEcCtD
L-Glutamine—GATB—testis—muscle cancer	0.00556	0.00811	CbGeAlD
L-Glutamine—CCBL1—testis—muscle cancer	0.00556	0.00811	CbGeAlD
L-Glutamine—GMPS—vagina—muscle cancer	0.00546	0.00798	CbGeAlD
L-Glutamine—CTPS1—vagina—muscle cancer	0.00546	0.00798	CbGeAlD
L-Glutamine—GLS—head—muscle cancer	0.00542	0.00791	CbGeAlD
L-Glutamine—GFPT2—vagina—muscle cancer	0.00536	0.00783	CbGeAlD
L-Glutamine—PFAS—vagina—muscle cancer	0.00536	0.00783	CbGeAlD
L-Glutamine—TGM2—head—muscle cancer	0.00536	0.00782	CbGeAlD
L-Glutamine—GLS—testis—muscle cancer	0.00523	0.00764	CbGeAlD
L-Glutamine—SLC1A5—smooth muscle tissue—muscle cancer	0.0052	0.00759	CbGeAlD
L-Glutamine—F13A1—tendon—muscle cancer	0.00519	0.00757	CbGeAlD
L-Glutamine—TGM2—testis—muscle cancer	0.00518	0.00756	CbGeAlD
L-Glutamine—CTPS1—head—muscle cancer	0.00505	0.00737	CbGeAlD
L-Glutamine—GMPS—head—muscle cancer	0.00505	0.00737	CbGeAlD
L-Glutamine—F13A1—bone marrow—muscle cancer	0.00502	0.00734	CbGeAlD
L-Glutamine—SLC1A5—renal system—muscle cancer	0.005	0.0073	CbGeAlD
L-Glutamine—TGM2—Alpha9 beta1 integrin signaling events—VEGFA—muscle cancer	0.00497	0.0477	CbGpPWpGaD
L-Glutamine—PFAS—head—muscle cancer	0.00495	0.00724	CbGeAlD
L-Glutamine—QARS—tendon—muscle cancer	0.00493	0.0072	CbGeAlD
L-Glutamine—CTPS1—testis—muscle cancer	0.00487	0.00712	CbGeAlD
L-Glutamine—GMPS—testis—muscle cancer	0.00487	0.00712	CbGeAlD
L-Glutamine—F13A1—vagina—muscle cancer	0.00481	0.00703	CbGeAlD
L-Glutamine—PFAS—testis—muscle cancer	0.00479	0.00699	CbGeAlD
L-Glutamine—GFPT2—testis—muscle cancer	0.00479	0.00699	CbGeAlD
L-Glutamine—QARS—bone marrow—muscle cancer	0.00478	0.00697	CbGeAlD
L-Glutamine—Nail disorder—Etoposide—muscle cancer	0.00469	0.0222	CcSEcCtD
L-Glutamine—GLUL—embryo—muscle cancer	0.00463	0.00676	CbGeAlD
L-Glutamine—QARS—vagina—muscle cancer	0.00457	0.00668	CbGeAlD
L-Glutamine—CAD—tendon—muscle cancer	0.00455	0.00664	CbGeAlD
L-Glutamine—SLC7A8—renal system—muscle cancer	0.0045	0.00658	CbGeAlD
L-Glutamine—SLC1A5—cardiac atrium—muscle cancer	0.00448	0.00654	CbGeAlD
L-Glutamine—ASNS—smooth muscle tissue—muscle cancer	0.00446	0.00651	CbGeAlD
L-Glutamine—F13A1—head—muscle cancer	0.00445	0.00649	CbGeAlD
L-Glutamine—CAD—bone marrow—muscle cancer	0.0044	0.00643	CbGeAlD
L-Glutamine—F13A1—testis—muscle cancer	0.00429	0.00627	CbGeAlD
L-Glutamine—Rectal tenesmus—Doxorubicin—muscle cancer	0.00423	0.0201	CcSEcCtD
L-Glutamine—QARS—head—muscle cancer	0.00423	0.00617	CbGeAlD
L-Glutamine—CAD—vagina—muscle cancer	0.00422	0.00616	CbGeAlD
L-Glutamine—PPAT—tendon—muscle cancer	0.00422	0.00616	CbGeAlD
L-Glutamine—PPAT—bone marrow—muscle cancer	0.00408	0.00596	CbGeAlD
L-Glutamine—QARS—testis—muscle cancer	0.00408	0.00596	CbGeAlD
L-Glutamine—Bacterial infection—Methotrexate—muscle cancer	0.00395	0.0187	CcSEcCtD
L-Glutamine—PPAT—vagina—muscle cancer	0.00391	0.00571	CbGeAlD
L-Glutamine—SLC1A5—tendon—muscle cancer	0.0039	0.0057	CbGeAlD
L-Glutamine—CAD—head—muscle cancer	0.0039	0.00569	CbGeAlD
L-Glutamine—GFPT2—Metabolism of proteins—TIMM10—muscle cancer	0.00387	0.0371	CbGpPWpGaD
L-Glutamine—ASNS—cardiac atrium—muscle cancer	0.00384	0.00561	CbGeAlD
L-Glutamine—SLC1A5—bone marrow—muscle cancer	0.00378	0.00552	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—HMGA1—muscle cancer	0.00377	0.0361	CbGpPWpGaD
L-Glutamine—CAD—testis—muscle cancer	0.00377	0.0055	CbGeAlD
L-Glutamine—Rigors—Etoposide—muscle cancer	0.00372	0.0177	CcSEcCtD
L-Glutamine—Sepsis—Dactinomycin—muscle cancer	0.00365	0.0173	CcSEcCtD
L-Glutamine—GLUL—smooth muscle tissue—muscle cancer	0.00364	0.00532	CbGeAlD
L-Glutamine—SLC1A5—vagina—muscle cancer	0.00362	0.00529	CbGeAlD
L-Glutamine—PPAT—head—muscle cancer	0.00361	0.00528	CbGeAlD
L-Glutamine—SLC7A8—tendon—muscle cancer	0.00352	0.00513	CbGeAlD
L-Glutamine—GLUL—renal system—muscle cancer	0.0035	0.00512	CbGeAlD
L-Glutamine—PPAT—testis—muscle cancer	0.00349	0.0051	CbGeAlD
L-Glutamine—Proctalgia—Doxorubicin—muscle cancer	0.00336	0.016	CcSEcCtD
L-Glutamine—F13A1—Alpha9 beta1 integrin signaling events—VEGFA—muscle cancer	0.00336	0.0322	CbGpPWpGaD
L-Glutamine—ASNS—tendon—muscle cancer	0.00335	0.00489	CbGeAlD
L-Glutamine—SLC1A5—head—muscle cancer	0.00335	0.00489	CbGeAlD
L-Glutamine—SLC7A8—vagina—muscle cancer	0.00326	0.00476	CbGeAlD
L-Glutamine—ASNS—bone marrow—muscle cancer	0.00324	0.00474	CbGeAlD
L-Glutamine—SLC1A5—testis—muscle cancer	0.00323	0.00472	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—IGF2—muscle cancer	0.00316	0.0303	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—ANGPT2—muscle cancer	0.00315	0.0302	CbGpPWpGaD
L-Glutamine—ASNS—vagina—muscle cancer	0.00311	0.00454	CbGeAlD
L-Glutamine—SLC7A8—head—muscle cancer	0.00301	0.0044	CbGeAlD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—IGF2—muscle cancer	0.00301	0.0288	CbGpPWpGaD
L-Glutamine—SLC7A8—testis—muscle cancer	0.00291	0.00425	CbGeAlD
L-Glutamine—Candida infection—Etoposide—muscle cancer	0.0029	0.0138	CcSEcCtD
L-Glutamine—Anorectal discomfort—Doxorubicin—muscle cancer	0.00288	0.0137	CcSEcCtD
L-Glutamine—Nail disorder—Methotrexate—muscle cancer	0.00281	0.0133	CcSEcCtD
L-Glutamine—ASNS—testis—muscle cancer	0.00277	0.00405	CbGeAlD
L-Glutamine—GLUL—tendon—muscle cancer	0.00274	0.004	CbGeAlD
L-Glutamine—Gastric ulcer—Doxorubicin—muscle cancer	0.00271	0.0129	CcSEcCtD
L-Glutamine—GLUL—bone marrow—muscle cancer	0.00265	0.00387	CbGeAlD
L-Glutamine—Sepsis—Etoposide—muscle cancer	0.00264	0.0125	CcSEcCtD
L-Glutamine—Enlargement abdomen—Doxorubicin—muscle cancer	0.00262	0.0124	CcSEcCtD
L-Glutamine—GLUL—vagina—muscle cancer	0.00254	0.00371	CbGeAlD
L-Glutamine—Dehydration—Vincristine—muscle cancer	0.00253	0.012	CcSEcCtD
L-Glutamine—Nail disorder—Doxorubicin—muscle cancer	0.00243	0.0115	CcSEcCtD
L-Glutamine—Fungal infection—Methotrexate—muscle cancer	0.00236	0.0112	CcSEcCtD
L-Glutamine—GLUL—head—muscle cancer	0.00235	0.00342	CbGeAlD
L-Glutamine—TGM2—Beta1 integrin cell surface interactions—VEGFA—muscle cancer	0.00229	0.0219	CbGpPWpGaD
L-Glutamine—GLUL—testis—muscle cancer	0.00227	0.00331	CbGeAlD
L-Glutamine—Laryngitis—Doxorubicin—muscle cancer	0.00219	0.0104	CcSEcCtD
L-Glutamine—Pharyngitis—Dactinomycin—muscle cancer	0.00209	0.00993	CcSEcCtD
L-Glutamine—Depression—Vincristine—muscle cancer	0.00209	0.00993	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—TIMM10—muscle cancer	0.00209	0.02	CbGpPWpGaD
L-Glutamine—SLC16A10—tendon—muscle cancer	0.00209	0.00305	CbGeAlD
L-Glutamine—Neuropathy peripheral—Vincristine—muscle cancer	0.00206	0.00976	CcSEcCtD
L-Glutamine—Fungal infection—Doxorubicin—muscle cancer	0.00204	0.00969	CcSEcCtD
L-Glutamine—SLC16A10—vagina—muscle cancer	0.00194	0.00283	CbGeAlD
L-Glutamine—Rigors—Doxorubicin—muscle cancer	0.00193	0.00916	CcSEcCtD
L-Glutamine—Injection site pain—Doxorubicin—muscle cancer	0.00193	0.00916	CcSEcCtD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	0.0019	0.0182	CbGpPWpGaD
L-Glutamine—Chills—Dactinomycin—muscle cancer	0.00189	0.00898	CcSEcCtD
L-Glutamine—Urinary tract disorder—Vincristine—muscle cancer	0.00186	0.00883	CcSEcCtD
L-Glutamine—Sweating increased—Etoposide—muscle cancer	0.00186	0.00882	CcSEcCtD
L-Glutamine—Urethral disorder—Vincristine—muscle cancer	0.00185	0.00877	CcSEcCtD
L-Glutamine—Breast pain—Doxorubicin—muscle cancer	0.00181	0.00858	CcSEcCtD
L-Glutamine—Viral infection—Doxorubicin—muscle cancer	0.00175	0.00828	CcSEcCtD
L-Glutamine—SLC16A10—testis—muscle cancer	0.00173	0.00252	CbGeAlD
L-Glutamine—Angiopathy—Vincristine—muscle cancer	0.00171	0.00811	CcSEcCtD
L-Glutamine—Ill-defined disorder—Dactinomycin—muscle cancer	0.0017	0.00808	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Etoposide—muscle cancer	0.00167	0.00791	CcSEcCtD
L-Glutamine—Malaise—Dactinomycin—muscle cancer	0.00166	0.00786	CcSEcCtD
L-Glutamine—Mental disorder—Vincristine—muscle cancer	0.00165	0.00783	CcSEcCtD
L-Glutamine—Back pain—Vincristine—muscle cancer	0.00159	0.00753	CcSEcCtD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—muscle cancer	0.00158	0.0151	CbGpPWpGaD
L-Glutamine—Sepsis—Methotrexate—muscle cancer	0.00158	0.0075	CcSEcCtD
L-Glutamine—Injection site reaction—Doxorubicin—muscle cancer	0.00157	0.00744	CcSEcCtD
L-Glutamine—Myalgia—Dactinomycin—muscle cancer	0.00156	0.00742	CcSEcCtD
L-Glutamine—F13A1—Beta1 integrin cell surface interactions—VEGFA—muscle cancer	0.00155	0.0148	CbGpPWpGaD
L-Glutamine—Discomfort—Dactinomycin—muscle cancer	0.00155	0.00733	CcSEcCtD
L-Glutamine—Urinary tract disorder—Etoposide—muscle cancer	0.00151	0.00715	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—muscle cancer	0.00151	0.00714	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—muscle cancer	0.0015	0.00711	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—muscle cancer	0.0015	0.0071	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—muscle cancer	0.00149	0.00706	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—ANGPT2—muscle cancer	0.00149	0.0142	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—IGF2—muscle cancer	0.0014	0.0134	CbGpPWpGaD
L-Glutamine—Myalgia—Vincristine—muscle cancer	0.0014	0.00663	CcSEcCtD
L-Glutamine—Angiopathy—Etoposide—muscle cancer	0.00139	0.00657	CcSEcCtD
L-Glutamine—Chills—Etoposide—muscle cancer	0.00137	0.0065	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—muscle cancer	0.00137	0.00649	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—muscle cancer	0.00137	0.00648	CcSEcCtD
L-Glutamine—Oedema—Vincristine—muscle cancer	0.00134	0.00635	CcSEcCtD
L-Glutamine—Infection—Vincristine—muscle cancer	0.00133	0.00631	CcSEcCtD
L-Glutamine—F13A1—Platelet degranulation—VEGFA—muscle cancer	0.00133	0.0127	CbGpPWpGaD
L-Glutamine—Hepatic function abnormal—Doxorubicin—muscle cancer	0.00131	0.00621	CcSEcCtD
L-Glutamine—Hyperhidrosis—Vincristine—muscle cancer	0.00129	0.00614	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—muscle cancer	0.00129	0.00613	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—FH—muscle cancer	0.00129	0.0123	CbGpPWpGaD
L-Glutamine—Back pain—Etoposide—muscle cancer	0.00129	0.0061	CcSEcCtD
L-Glutamine—Pain—Dactinomycin—muscle cancer	0.00128	0.00608	CcSEcCtD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—VEGFA—muscle cancer	0.00126	0.0121	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Dactinomycin—muscle cancer	0.00124	0.00586	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—muscle cancer	0.00123	0.00585	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Dactinomycin—muscle cancer	0.00123	0.00581	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vincristine—muscle cancer	0.00122	0.00579	CcSEcCtD
L-Glutamine—Insomnia—Vincristine—muscle cancer	0.00121	0.00575	CcSEcCtD
L-Glutamine—Malaise—Etoposide—muscle cancer	0.0012	0.00569	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—muscle cancer	0.00119	0.00562	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—muscle cancer	0.00119	0.00562	CcSEcCtD
L-Glutamine—Fatigue—Vincristine—muscle cancer	0.00115	0.00548	CcSEcCtD
L-Glutamine—GMPS—Metabolism—FH—muscle cancer	0.00115	0.011	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—FH—muscle cancer	0.00115	0.011	CbGpPWpGaD
L-Glutamine—Pain—Vincristine—muscle cancer	0.00115	0.00543	CcSEcCtD
L-Glutamine—Constipation—Vincristine—muscle cancer	0.00115	0.00543	CcSEcCtD
L-Glutamine—Chest pain—Etoposide—muscle cancer	0.00113	0.00537	CcSEcCtD
L-Glutamine—Pancreatitis—Methotrexate—muscle cancer	0.00112	0.00531	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—muscle cancer	0.00112	0.0053	CcSEcCtD
L-Glutamine—Hypersensitivity—Dactinomycin—muscle cancer	0.0011	0.00524	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vincristine—muscle cancer	0.0011	0.0052	CcSEcCtD
L-Glutamine—Infection—Etoposide—muscle cancer	0.00108	0.00511	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—muscle cancer	0.00108	0.0051	CcSEcCtD
L-Glutamine—Dehydration—Doxorubicin—muscle cancer	0.00106	0.00505	CcSEcCtD
L-Glutamine—Abdominal pain—Vincristine—muscle cancer	0.00106	0.00502	CcSEcCtD
L-Glutamine—Body temperature increased—Vincristine—muscle cancer	0.00106	0.00502	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—FH—muscle cancer	0.00105	0.01	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Etoposide—muscle cancer	0.00105	0.00498	CcSEcCtD
L-Glutamine—Depression—Methotrexate—muscle cancer	0.00102	0.00482	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—muscle cancer	0.000996	0.00473	CcSEcCtD
L-Glutamine—Hypersensitivity—Vincristine—muscle cancer	0.000987	0.00468	CcSEcCtD
L-Glutamine—Pancreatitis—Doxorubicin—muscle cancer	0.00097	0.0046	CcSEcCtD
L-Glutamine—Asthenia—Vincristine—muscle cancer	0.000961	0.00456	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—muscle cancer	0.000953	0.00452	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—muscle cancer	0.000945	0.00448	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—muscle cancer	0.000935	0.00444	CcSEcCtD
L-Glutamine—Constipation—Etoposide—muscle cancer	0.000928	0.0044	CcSEcCtD
L-Glutamine—Pain—Etoposide—muscle cancer	0.000928	0.0044	CcSEcCtD
L-Glutamine—GLS2—Metabolism—FH—muscle cancer	0.000917	0.00878	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—FH—muscle cancer	0.000917	0.00878	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—FH—muscle cancer	0.000917	0.00878	CbGpPWpGaD
L-Glutamine—Pharyngitis—Methotrexate—muscle cancer	0.000908	0.00431	CcSEcCtD
L-Glutamine—Urinary tract disorder—Methotrexate—muscle cancer	0.000903	0.00428	CcSEcCtD
L-Glutamine—Urethral disorder—Methotrexate—muscle cancer	0.000897	0.00425	CcSEcCtD
L-Glutamine—Feeling abnormal—Etoposide—muscle cancer	0.000894	0.00424	CcSEcCtD
L-Glutamine—Nausea—Dactinomycin—muscle cancer	0.00089	0.00422	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—muscle cancer	0.000887	0.00421	CcSEcCtD
L-Glutamine—Dizziness—Vincristine—muscle cancer	0.000886	0.0042	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000884	0.00847	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000884	0.00847	CbGpPWpGaD
L-Glutamine—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000865	0.0041	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—muscle cancer	0.00086	0.00824	CbGpPWpGaD
L-Glutamine—Abdominal pain—Etoposide—muscle cancer	0.000858	0.00407	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—muscle cancer	0.000858	0.00407	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—ANGPT2—muscle cancer	0.000853	0.00817	CbGpPWpGaD
L-Glutamine—Vomiting—Vincristine—muscle cancer	0.000852	0.00404	CcSEcCtD
L-Glutamine—Rash—Vincristine—muscle cancer	0.000844	0.00401	CcSEcCtD
L-Glutamine—Dermatitis—Vincristine—muscle cancer	0.000844	0.004	CcSEcCtD
L-Glutamine—Headache—Vincristine—muscle cancer	0.000839	0.00398	CcSEcCtD
L-Glutamine—QARS—Gene Expression—MED12—muscle cancer	0.000833	0.00798	CbGpPWpGaD
L-Glutamine—Angiopathy—Methotrexate—muscle cancer	0.00083	0.00394	CcSEcCtD
L-Glutamine—Chills—Methotrexate—muscle cancer	0.000821	0.00389	CcSEcCtD
L-Glutamine—Mental disorder—Methotrexate—muscle cancer	0.000801	0.0038	CcSEcCtD
L-Glutamine—Hypersensitivity—Etoposide—muscle cancer	0.000799	0.00379	CcSEcCtD
L-Glutamine—Malnutrition—Methotrexate—muscle cancer	0.000796	0.00378	CcSEcCtD
L-Glutamine—Nausea—Vincristine—muscle cancer	0.000796	0.00377	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—muscle cancer	0.000794	0.00377	CcSEcCtD
L-Glutamine—Pharyngitis—Doxorubicin—muscle cancer	0.000786	0.00373	CcSEcCtD
L-Glutamine—Urinary tract disorder—Doxorubicin—muscle cancer	0.000782	0.00371	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—muscle cancer	0.000778	0.00369	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—muscle cancer	0.000776	0.00368	CcSEcCtD
L-Glutamine—Back pain—Methotrexate—muscle cancer	0.00077	0.00365	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—muscle cancer	0.000768	0.00364	CcSEcCtD
L-Glutamine—CAD—Metabolism—FH—muscle cancer	0.000739	0.00708	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Methotrexate—muscle cancer	0.000739	0.0035	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—MED12—muscle cancer	0.000727	0.00696	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—IGF2—muscle cancer	0.000722	0.00692	CbGpPWpGaD
L-Glutamine—Angiopathy—Doxorubicin—muscle cancer	0.000719	0.00341	CcSEcCtD
L-Glutamine—Malaise—Methotrexate—muscle cancer	0.000718	0.00341	CcSEcCtD
L-Glutamine—Dizziness—Etoposide—muscle cancer	0.000717	0.0034	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—muscle cancer	0.000711	0.00337	CcSEcCtD
L-Glutamine—Mental disorder—Doxorubicin—muscle cancer	0.000694	0.00329	CcSEcCtD
L-Glutamine—Vomiting—Etoposide—muscle cancer	0.00069	0.00327	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—muscle cancer	0.000689	0.00327	CcSEcCtD
L-Glutamine—Rash—Etoposide—muscle cancer	0.000684	0.00324	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—muscle cancer	0.000683	0.00324	CcSEcCtD
L-Glutamine—Headache—Etoposide—muscle cancer	0.00068	0.00322	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—muscle cancer	0.000679	0.00322	CcSEcCtD
L-Glutamine—Chest pain—Methotrexate—muscle cancer	0.000678	0.00322	CcSEcCtD
L-Glutamine—Myalgia—Methotrexate—muscle cancer	0.000678	0.00322	CcSEcCtD
L-Glutamine—Arthralgia—Methotrexate—muscle cancer	0.000678	0.00322	CcSEcCtD
L-Glutamine—GLS—Neuronal System—MDM2—muscle cancer	0.000678	0.00649	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—MDM2—muscle cancer	0.000678	0.00649	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—FH—muscle cancer	0.000676	0.00647	CbGpPWpGaD
L-Glutamine—Discomfort—Methotrexate—muscle cancer	0.00067	0.00318	CcSEcCtD
L-Glutamine—Back pain—Doxorubicin—muscle cancer	0.000667	0.00316	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ENO2—muscle cancer	0.000663	0.00635	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—MED12—muscle cancer	0.000648	0.00621	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—MED12—muscle cancer	0.000648	0.00621	CbGpPWpGaD
L-Glutamine—Infection—Methotrexate—muscle cancer	0.000646	0.00306	CcSEcCtD
L-Glutamine—NADSYN1—Disease—ENO2—muscle cancer	0.000645	0.00618	CbGpPWpGaD
L-Glutamine—Nausea—Etoposide—muscle cancer	0.000644	0.00306	CcSEcCtD
L-Glutamine—Ill-defined disorder—Doxorubicin—muscle cancer	0.00064	0.00303	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—IGF2—muscle cancer	0.000638	0.00611	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Methotrexate—muscle cancer	0.000628	0.00298	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—muscle cancer	0.000622	0.00295	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—MED12—muscle cancer	0.000593	0.00568	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000592	0.00281	CcSEcCtD
L-Glutamine—PFAS—Metabolism—ENO2—muscle cancer	0.000591	0.00566	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—ENO2—muscle cancer	0.000591	0.00566	CbGpPWpGaD
L-Glutamine—Insomnia—Methotrexate—muscle cancer	0.000588	0.00279	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—VEGFA—muscle cancer	0.000588	0.00563	CbGpPWpGaD
L-Glutamine—Arthralgia—Doxorubicin—muscle cancer	0.000587	0.00278	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—muscle cancer	0.000587	0.00278	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—muscle cancer	0.000587	0.00278	CcSEcCtD
L-Glutamine—NADSYN1—Disease—HMGA1—muscle cancer	0.000586	0.00562	CbGpPWpGaD
L-Glutamine—Discomfort—Doxorubicin—muscle cancer	0.00058	0.00275	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—muscle cancer	0.000574	0.00272	CcSEcCtD
L-Glutamine—CCBL1—Disease—ENO2—muscle cancer	0.000564	0.0054	CbGpPWpGaD
L-Glutamine—Oedema—Doxorubicin—muscle cancer	0.000563	0.00267	CcSEcCtD
L-Glutamine—Fatigue—Methotrexate—muscle cancer	0.00056	0.00266	CcSEcCtD
L-Glutamine—Infection—Doxorubicin—muscle cancer	0.000559	0.00265	CcSEcCtD
L-Glutamine—Pain—Methotrexate—muscle cancer	0.000556	0.00264	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—muscle cancer	0.000544	0.00258	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—ENO2—muscle cancer	0.00054	0.00518	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Methotrexate—muscle cancer	0.000536	0.00254	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Methotrexate—muscle cancer	0.000531	0.00252	CcSEcCtD
L-Glutamine—GLUL—Metabolism—FH—muscle cancer	0.000527	0.00504	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—FH—muscle cancer	0.000527	0.00504	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FOXO4—muscle cancer	0.000526	0.00504	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—MED12—muscle cancer	0.000518	0.00496	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—MED12—muscle cancer	0.000518	0.00496	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—MED12—muscle cancer	0.000518	0.00496	CbGpPWpGaD
L-Glutamine—Abdominal pain—Methotrexate—muscle cancer	0.000514	0.00244	CcSEcCtD
L-Glutamine—Body temperature increased—Methotrexate—muscle cancer	0.000514	0.00244	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000513	0.00243	CcSEcCtD
L-Glutamine—CCBL1—Disease—HMGA1—muscle cancer	0.000513	0.00491	CbGpPWpGaD
L-Glutamine—Insomnia—Doxorubicin—muscle cancer	0.000509	0.00241	CcSEcCtD
L-Glutamine—GLUL—Transmission across Chemical Synapses—MDM2—muscle cancer	0.000508	0.00487	CbGpPWpGaD
L-Glutamine—Fatigue—Doxorubicin—muscle cancer	0.000485	0.0023	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—muscle cancer	0.000481	0.00228	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—muscle cancer	0.000481	0.00228	CcSEcCtD
L-Glutamine—Hypersensitivity—Methotrexate—muscle cancer	0.000479	0.00227	CcSEcCtD
L-Glutamine—GLS2—Metabolism—ENO2—muscle cancer	0.000472	0.00452	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ENO2—muscle cancer	0.000472	0.00452	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ENO2—muscle cancer	0.000472	0.00452	CbGpPWpGaD
L-Glutamine—Asthenia—Methotrexate—muscle cancer	0.000466	0.00221	CcSEcCtD
L-Glutamine—Feeling abnormal—Doxorubicin—muscle cancer	0.000464	0.0022	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00046	0.00218	CcSEcCtD
L-Glutamine—Pruritus—Methotrexate—muscle cancer	0.00046	0.00218	CcSEcCtD
L-Glutamine—CCBL1—Disease—FOXO4—muscle cancer	0.00046	0.0044	CbGpPWpGaD
L-Glutamine—Body temperature increased—Doxorubicin—muscle cancer	0.000445	0.00211	CcSEcCtD
L-Glutamine—Abdominal pain—Doxorubicin—muscle cancer	0.000445	0.00211	CcSEcCtD
L-Glutamine—Dizziness—Methotrexate—muscle cancer	0.00043	0.00204	CcSEcCtD
L-Glutamine—CAD—Metabolism—MED12—muscle cancer	0.000418	0.004	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—IGF2—muscle cancer	0.000415	0.00397	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—muscle cancer	0.000415	0.00197	CcSEcCtD
L-Glutamine—Vomiting—Methotrexate—muscle cancer	0.000413	0.00196	CcSEcCtD
L-Glutamine—Rash—Methotrexate—muscle cancer	0.00041	0.00194	CcSEcCtD
L-Glutamine—Dermatitis—Methotrexate—muscle cancer	0.000409	0.00194	CcSEcCtD
L-Glutamine—Headache—Methotrexate—muscle cancer	0.000407	0.00193	CcSEcCtD
L-Glutamine—Asthenia—Doxorubicin—muscle cancer	0.000404	0.00192	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—muscle cancer	0.000398	0.00189	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—MDM2—muscle cancer	0.000389	0.00373	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—FOXO1—muscle cancer	0.000388	0.00372	CbGpPWpGaD
L-Glutamine—Nausea—Methotrexate—muscle cancer	0.000386	0.00183	CcSEcCtD
L-Glutamine—PPAT—Metabolism—MED12—muscle cancer	0.000382	0.00366	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ENO2—muscle cancer	0.000381	0.00365	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—muscle cancer	0.000372	0.00177	CcSEcCtD
L-Glutamine—Vomiting—Doxorubicin—muscle cancer	0.000358	0.0017	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—muscle cancer	0.000355	0.00168	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—muscle cancer	0.000354	0.00168	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—muscle cancer	0.000353	0.00167	CcSEcCtD
L-Glutamine—PPAT—Metabolism—ENO2—muscle cancer	0.000348	0.00334	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism of proteins—IGF2—muscle cancer	0.000344	0.0033	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—FOXO1—muscle cancer	0.00034	0.00325	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—muscle cancer	0.000334	0.00159	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—VEGFA—muscle cancer	0.000303	0.0029	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—MED12—muscle cancer	0.000298	0.00285	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—MED12—muscle cancer	0.000298	0.00285	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—KIT—muscle cancer	0.000296	0.00284	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—muscle cancer	0.000271	0.0026	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—muscle cancer	0.000271	0.0026	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—KIT—muscle cancer	0.000259	0.00248	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MDM2—muscle cancer	0.000233	0.00223	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PTGS2—muscle cancer	0.000231	0.00221	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—muscle cancer	0.000229	0.00219	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PTGS2—muscle cancer	0.000225	0.00215	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—PTGS2—muscle cancer	0.000206	0.00197	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PTGS2—muscle cancer	0.000206	0.00197	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MDM2—muscle cancer	0.000204	0.00195	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—PTGS2—muscle cancer	0.000196	0.00188	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—PTGS2—muscle cancer	0.000188	0.0018	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—VEGFA—muscle cancer	0.000174	0.00167	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PTGS2—muscle cancer	0.000164	0.00158	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PTGS2—muscle cancer	0.000164	0.00158	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PTGS2—muscle cancer	0.000164	0.00158	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PTGS2—muscle cancer	0.000133	0.00127	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—muscle cancer	0.000131	0.00126	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PTGS2—muscle cancer	0.000121	0.00116	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—PTGS2—muscle cancer	9.45e-05	0.000905	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PTGS2—muscle cancer	9.45e-05	0.000905	CbGpPWpGaD
